Greenland Mines Ltd (NASDAQ: GRML) is strengthening its foothold in the critical minerals sector through the development of its Skaergaard palladium-gold-platinum project and the planned acquisition of the Sarfartoq neodymium-praseodymium (NdPr) rare-earths project in Greenland. These initiatives align with growing Western efforts to secure supply chains for metals essential to clean energy, defense, and advanced technologies.
The Skaergaard project, located in southeast Greenland, hosts a substantial palladium-equivalent resource. An independent sensitivity study by SLR Consulting recently highlighted the project's significant leverage to metal prices. According to company disclosures, the project contains an NI 43-101 mineral resource of 11.4 million ounces palladium-equivalent (PdEq) indicated and 14.1 million ounces PdEq inferred. However, the company cautions that mineral resources are not mineral reserves and do not have demonstrated economic viability, and no preliminary economic assessment or feasibility study has been completed.
In addition to Skaergaard, Greenland Mines is acquiring the Sarfartoq rare-earth project in southwest Greenland. This transaction will add an advanced rare-earths asset to the company's portfolio and establish Neo Performance Materials as a strategic shareholder and future offtake partner. NdPr is a critical input for permanent magnets used in electric vehicles and wind turbines, making the project strategically important for Western supply chains.
Greenland Mines joins a group of companies focused on strengthening Western critical minerals supply chains, including Platinum Group Metals Ltd. (NYSE American: PLG; TSX: PTM), Valterra Platinum Limited (JSE: VAL; OTC: ANGPY), Aclara Resources Inc. (TSX: ARA), and The Metals Company (NASDAQ: TMC). Commentary highlights Greenland Mines' unique position across both platinum-group metals and rare earths in a Western-aligned jurisdiction, providing exposure to two strategically important mineral markets that have become increasingly important to governments, manufacturers, and investors seeking alternatives to Chinese and Russian supply sources.
The company operates through two divisions: Mining, focused on the Skaergaard and Sarfartoq projects, and Biotech, including Klotho's KLTO-202 primary indication for ALS. Greenland Mines is led by an experienced team of mining, geological, biotech, and capital markets professionals. For more information, visit https://greenlandmines.com/.
